SARS-CoV-2 mRNA vaccines induce a robust germinal centre reaction in humans
Ali H. Ellebedy(Washington University in St. Louis), Pei‐Yong Shi(The University of Texas Medical Branch at Galveston), Jane A. O’Halloran(St. Vincent's University Hospital), Wooseob Kim(Korea University), Xuping Xie(The University of Texas Medical Branch at Galveston), Alem Haile(Washington University in St. Louis), Adriana M. Rauseo(Washington University in St. Louis), Tingting Lei(Washington University in St. Louis), James Brett Case(Washington University in St. Louis), Rachel M. Presti(Johns Hopkins University), Aaron J. Schmitz(Washington University in St. Louis), William D. Middleton(Mallinckrodt (United States)), Fatima Amanat(Icahn School of Medicine at Mount Sinai), Elizaveta Kalaidina(Washington University in St. Louis), Jackson S. Turner(Washington University in St. Louis), Mahima Thapa(Washington University in St. Louis), Michael Diamond(Washington University in St. Louis), Florian Krammer(Semmelweis University), Michael K. Klebert(Washington University in St. Louis), Teresa Suessen(Mallinckrodt (United States)), Rita Chen, Sharlene A. Teefey(Mallinckrodt (United States))
Cited by 14
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
The continued threat of emerging flaviviruses
|Nature Microbiology|2020|1.1k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
|Nature Immunology|2020|997